Alfons J M van den Eertwegh

Alfons J M van den Eertwegh

UNVERIFIED PROFILE

Are you Alfons J M van den Eertwegh?   Register this Author

Register author
Alfons J M van den Eertwegh

Alfons J M van den Eertwegh

Publications by authors named "Alfons J M van den Eertwegh"

Are you Alfons J M van den Eertwegh?   Register this Author

100Publications

2447Reads

22Profile Views

Systematic Review on Infusion Reactions to and Infusion Rate of Monoclonal Antibodies Used in Cancer Treatment.

Anticancer Res 2020 Mar;40(3):1201-1218

Department of Clinical Pharmacy and Pharmacology, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.14062DOI Listing
March 2020

Simplified Methods for Quantification of F-DCFPyL Uptake in Patients with Prostate Cancer.

J Nucl Med 2019 Dec 18;60(12):1730-1735. Epub 2019 Apr 18.

Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.119.227
Publisher Site
http://dx.doi.org/10.2967/jnumed.119.227520DOI Listing
December 2019

[Endocrine side effects of checkpoint inhibitors].

Ned Tijdschr Geneeskd 2019 10 31;163. Epub 2019 Oct 31.

Amsterdam UMC, locatie VUmc, Afd. Interne Geneeskunde, sectie Endocrinologie, Amsterdam.

View Article

Download full-text PDF

Source
October 2019

Sensitivity of F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer.

EJNMMI Res 2019 Jul 30;9(1):70. Epub 2019 Jul 30.

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13550-019-0531-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667590PMC
July 2019

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

J Clin Oncol 2018 08 10;36(24):2504-2513. Epub 2018 Jul 10.

Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.4174DOI Listing
August 2018

Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence.

Cancer Immunol Res 2017 11 21;5(11):969-977. Epub 2017 Sep 21.

Department of Medical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0110DOI Listing
November 2017

Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS.

Neurology 2017 08 2;89(9):970-972. Epub 2017 Aug 2.

From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bosch Hospital, 's-Hertogenbosch; and Department of Neurology (J.P.M.), Rijnstate Hospital, Arnhem, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004293DOI Listing
August 2017

A Phase 1 Trial of Cabazitaxel Combined With 188Re-Hydroxyethylidene Diphosphonate in Patients With Metastatic Castration-Resistant Prostate Cancer Who Progressed on or After a Docetaxel-Containing Treatment: The ReCab Trial.

Clin Nucl Med 2017 Jun;42(6):415-420

From the *Department of Medical Oncology, VU University Medical Center, Amsterdam; †Department of Medical Oncology, Meander Medical Center, Amersfoort; ‡Department of Medical Oncology, UMC Utrecht; and §Department of Nuclear Medicine, Meander Medical Center, Amersfoort, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001604DOI Listing
June 2017

Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies.

J Nucl Med 2016 10 26;57(10):1642-1649. Epub 2016 May 26.

Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.173831DOI Listing
October 2016

Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.

Eur Urol 2016 09 19;70(3):416-26. Epub 2015 Sep 19.

Department of Medical Oncology, VU University Medical Centre, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.09.005DOI Listing
September 2016

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.

Cancer Inform 2016 15;15:115-27. Epub 2016 Jun 15.

Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CIN.S38122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912231PMC
June 2016

Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.

J Nucl Med 2016 May 23;57(5):721-7. Epub 2015 Dec 23.

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.167692DOI Listing
May 2016

Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node.

Cancer Immunol Immunother 2016 Apr 2;65(4):405-15. Epub 2016 Mar 2.

Department of Medical Oncology, Cancer Center Amsterdam, Vrije Universiteit (VU) University Medical Center, De Boelelaan 1117, Room CCA 2.44, 1081 HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1811-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826413PMC
April 2016

Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.

Curr Opin Oncol 2015 Nov;27(6):482-8

Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000221DOI Listing
November 2015

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems.

Mol Imaging Biol 2015 Oct;17(5):714-25

Department of Radiology and Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-015-0826-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768240PMC
October 2015

New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?

Clin Genitourin Cancer 2015 Aug 21;13(4):271-279. Epub 2015 Jan 21.

Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.01.008DOI Listing
August 2015

[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.

Mol Imaging Biol 2015 Jun;17(3):319-27

Department of Radiology and Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-014-0803-7DOI Listing
June 2015

Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.

J Nucl Med 2015 Mar 12;56(3):365-71. Epub 2015 Feb 12.

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.114.148007DOI Listing
March 2015

New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies.

Anticancer Res 2014 Apr;34(4):1493-505

Department of Medical Oncology, VU University Medical Center, CCA 1.42, PO Box 7057,1007 MB Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/34/4/1493.full.pdf
Web Search
April 2014

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the Netherlands.

Clin Genitourin Cancer 2013 Sep 6;11(3):238-250.e1. Epub 2013 May 6.

Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.04.004DOI Listing
September 2013

ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro.

Anticancer Res 2013 Feb;33(2):387-91

Department of Radiology and Nuclear Medicine, Department of Urology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
February 2013

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

Clin Immunol 2011 Aug 18;140(2):130-41. Epub 2010 Dec 18.

Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2010.11.010DOI Listing
August 2011

Targeted therapy for renal cell cancer: current perspectives.

Discov Med 2010 Nov;10(54):394-405

Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
November 2010

Targeted therapies in renal cell cancer: recent developments in imaging.

Target Oncol 2010 Jun 14;5(2):95-112. Epub 2010 Jul 14.

Department of Nuclear Medicine & PET Research, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-010-0146-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929340PMC
June 2010

Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib.

Anticancer Drugs 2010 Apr;21(4):439-46

Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3283359c79DOI Listing
April 2010

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.

World J Urol 2009 Aug 15;27(4):533-9. Epub 2009 Jan 15.

Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-008-0368-7DOI Listing
August 2009

Human dendritic cell line models for DC differentiation and clinical DC vaccination studies.

J Leukoc Biol 2008 Dec 29;84(6):1364-73. Epub 2008 Jul 29.

Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0208092DOI Listing
December 2008

Invariant natural killer T cells and immunotherapy of cancer.

Clin Immunol 2008 Nov 9;129(2):182-94. Epub 2008 Sep 9.

Cancer Center Amsterdam, VUMC Institute for Cancer and Immunology, Division of Immune Therapy, Department of Medical Oncology, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2008.07.025DOI Listing
November 2008

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.

Cancer Immunol Immunother 2008 Oct 4;57(10):1569-77. Epub 2008 Jun 4.

Department of Medical Oncology, Vrije Universiteit medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0536-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491427PMC
October 2008

In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.

Clin Immunol 2008 Oct 15;129(1):145-54. Epub 2008 Aug 15.

Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2008.07.004DOI Listing
October 2008

Metastatic renal cell cancer in a 20-year-old pregnant woman.

Urology 2008 Oct 23;72(4):775; discussion 776-7. Epub 2008 Aug 23.

Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2008.04.048DOI Listing
October 2008

Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases.

Immunol Lett 2008 Jun 24;118(1):36-43. Epub 2008 Mar 24.

Cancer Center Amsterdam, VUMC Institute for Cancer and Immunology (V-ICI), Division of Immune Therapy, Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016524780800063
Publisher Site
http://dx.doi.org/10.1016/j.imlet.2008.02.007DOI Listing
June 2008

Sunitinib for treatment of advanced renal cell cancer: primary tumor response.

Clin Cancer Res 2008 Apr;14(8):2431-6

Department of Medical Oncology, VU University medical center, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-4089DOI Listing
April 2008

Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.

J Hepatol 2007 Sep 6;47(3):356-65. Epub 2007 Jun 6.

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Room Ca 326a, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2007.04.018DOI Listing
September 2007

Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.

J Immunol Methods 2007 Apr 23;322(1-2):70-81. Epub 2007 Feb 23.

VUMC Institute for Cancer and Immunology (V-ICI), Division of Immune Therapy, Department of Medical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2007.02.002DOI Listing
April 2007

Immunomodulation of the melanoma sentinel lymph node: a novel adjuvant therapeutic option.

Immunobiology 2006 28;211(6-8):651-61. Epub 2006 Jul 28.

Department of Surgical Oncology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imbio.2006.06.009DOI Listing
December 2006

The immunoregulatory role of CD1d-restricted natural killer T cells in disease.

Clin Immunol 2004 Jul;112(1):8-23

The Departments of Pathology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2004.03.003DOI Listing
July 2004

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.

Proc Natl Acad Sci U S A 2004 Jun 7;101(24):9057-62. Epub 2004 Jun 7.

Division of Immunology and Genetics, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0402949101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC428472PMC
June 2004